Navigation Links
NeoGenomics Announces Executive Appointments
Date:12/4/2009

FORT MYERS, Fla., Dec. 4 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that Steven C. Jones has been appointed Executive Vice President, Finance and that George A. Cardoza has joined the company as Chief Financial Officer. Mr. Cardoza will be responsible for managing all internal financial affairs of the Company. In his new role, Mr. Jones will focus on developing strategic initiatives on behalf of NeoGenomics as well as continue to serve as the Company's Director of Investor Relations.

Mr. Cardoza most recently served as Chief Financial Officer of Protocol Global Solutions, Inc., a privately held international marketing company. Prior to joining Protocol Global Solutions in 2006, Mr. Cardoza was employed by Quest Diagnostics in a variety of financial roles of increasing responsibility. While at Quest Diagnostics, George served as Controller of the Central Region with responsibility for 11 major laboratories.

Douglas VanOort, Chairman and Chief Executive Officer, stated, "I am delighted to welcome George Cardoza to NeoGenomics. I had the privilege of working with George for eight years during my own time at Quest Diagnostics and he brings outstanding financial management skills to our company. We are also very pleased to have Steve Jones lead strategic initiatives for our company in addition to his role in Investor Relations. Steve has served as "Acting CFO" for the last seven years, and brings wealth of experience and strategic skills to his new role. We are deeply indebted to him for his dedication and many contributions to the growth and success of NeoGenomics."

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluo
'/>"/>

SOURCE NeoGenomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
2. NeoGenomics Announces Results for the 3rd Quarter 2007
3. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
4. NeoGenomics to Present at the Noble Financial Equity Conference
5. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
6. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
7. NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
8. NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
9. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
10. NeoGenomics to Present at Noble Financials 5th Annual Equity Conference on Monday, June 8th
11. NeoGenomics Schedules Its Q2 2009 Earnings Release for July 28, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based ... practice and med-spa with the addition of new Silk ... cosmetic treatments and services. , “Silk Peel is a ... Dr. Ho. “As a result it can address issues ... spots, discolorations or blemishes.” , Similar to microdermabrasion, ...
(Date:12/24/2014)... Wilsonville, Oregon (PRWEB) December 24, 2014 ... Infinity Rehab sat down with Derek Fenwick, PT, ... legislative changes that will stem from the passing of ... 2014 (IMPACT Act). In this taping of the ... amends title XVIII of the Social Security Act to ...
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- A new, injectable weight-loss ... Drug Administration. The agency on Tuesday approved Saxenda ... who are overweight and have at least one weight-related ... diabetes or high cholesterol. Patients taking the drug, ... diet and exercise regularly, the FDA noted. "Obesity ...
(Date:12/24/2014)... Steven Reinberg HealthDay Reporter ... guidelines from the American Diabetes Association (ADA) call for giving ... diabetes to help prevent heart disease. These new standards ... Cardiology and American Heart Association, which also recommend giving low- ... disease, including people with diabetes. "We agree that the ...
(Date:12/24/2014)... 2014 The 2014 Market Research ... and in-depth research report on COC industry. For ... information, including its definition, classification, application, industry chain ... This report also presents product specification, manufacturing process, ... by regions, technology and applications. Analysis also covers ...
Breaking Medicine News(10 mins):Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3
... Using a novel imaging technique to study autistic children, ... areas that govern social processing and learning by observation. ... Lindner Center for Autism, North Shore-Long Island Jewish Health ... annual meeting of the Radiological Society of North America ...
... Advanced Laparoscopic Procedures through the Belly Button: Scar-Free ... ... CLEVELAND, Nov. 28 Cleveland Clinic urologists recently,performed a ... pyeloplasty (uretero-pelvic,junction repair), ileal ureter replacement, and psoas hitch uretero-,neocystostomy ...
... Inc., a leading,provider of medical image review services ... million Series B financing led by Siemens Venture,Capital ... Tang Capital Management participated in the financing., ... imaging and clinical,research, and we are delighted to ...
... of Transplantation Winter Symposium Kicks Off March ... ... Organ transplantation is,increasingly being offered to patients with multiple co-morbidities and ... has prompted the increasing use of donors with characteristics,that increase the risk ...
... first comprehensive review of evidence on pneumococcal conjugate vaccination ... the on-line edition of the journal Lancet Infectious Diseases, ... pneumococcal infection by up to 40 fold, that the ... and that the vaccine can protect HIV-infected infants. ...
... in Energy-based Surgical Systems Uses Intelligent Device Management,to ... Technologies, BOULDER, Colo. and REDWOOD CITY, Calif., ... ; BSX: COV), a world leader in advanced,energy-based ... Device Management (IDM), today announced the global launch ...
Cached Medicine News:Health News:Novel imaging technique shows gray matter increase in brains of autistic children 2Health News:World Firsts by Cleveland Clinic Urologists 2Health News:RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital 2Health News:RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital 3Health News:AST 'Emergence to Convergence' Highlights the Latest High-Risk Organ Donor and Recipient Issues 2Health News:Pneumococcal conjugate vaccines can improve the lives of HIV-infected children 2Health News:Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System 2Health News:Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System 3
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... Dec. 23, 2014 Tianyin Pharmaceutical Co., ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today announced that the Company achieved the Public ... Practice (GMP) certificate of TPI,s Qionglai Facility (QLF) ... The public notice period is a significant procedure ...
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Role of Medical Science Liaisons Evolving in Medical Device Sector 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: